Dr. Peter S. Nelson, M.D.
Dermatology (Dermatology Physician)
3030 North St, Suite 430 (beaumont Dermatology & Family Practice)
Beaumont, TX 77702
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 756
Licensed in Texas since 2008, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Louisiana State University School of Medicine in New Orleans
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TX license M9537 (first issued 2008; active) · LA license MD.201378
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Beaumont Dermatology and Family Practice, LLP (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 756
- Services billed
- 4,582
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,519 | 241 |
| Established patient office or other outpatient visit, 20-29 minutes | 566 | 393 |
| Established patient office or other outpatient visit, 30-39 minutes | 513 | 349 |
| Destruction of precancer skin growth, 1 growth | 455 | 313 |
| Destruction of skin growth, 1-14 growths | 379 | 307 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 299 | 45 |
| Biopsy of related skin growth, first growth | 286 | 240 |
| Biopsy of related skin growth, each additional growth | 108 | 78 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 93 | 34 |
| Injection of drug or substance under skin or into muscle | 83 | 35 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 29 payments worth $961 in total to this clinician.
| Janssen Biotech, Inc. | $293 |
|---|---|
| AbbVie Inc. | $201 |
| Genzyme Corporation | $149 |
| Lilly USA, LLC | $105 |
| Incyte Corporation | $94.29 |
| Arcutis Biotherapeutics, Inc. | $91.85 |
| Novartis Pharmaceuticals Corporation | $27.06 |
| Food and Beverage | $844 |
|---|---|
| Education | $118 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 24, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
| AbbVie Inc. Jan 8, 2025 | Education in-kind | $9.65 |
| Genzyme Corporation Mar 20, 2025 | Education in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $8.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.